PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|2|1|72-76

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.2, Iss.1, 2009-04, pp. : 72-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 57-59

Karger

Access to resources Recommend Favorite

PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-04 ,pp. : 181-186

Karger

Access to resources Recommend Favorite

Sequencing of Cabazitaxel in Metastatic Castrate-Resistant Prostate Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-06 ,pp. : 320-324

Karger

Access to resources Recommend Favorite

Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-06 ,pp. : 325-330

Karger

Access to resources Recommend Favorite

High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-06 ,pp. : 383-388

Karger

Access to resources Recommend Favorite